Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Rana Malek & Stephen N. Davis. (2016) Pharmacokinetics, efficacy and safety of glyburide for treatment of gestational diabetes mellitus. Expert Opinion on Drug Metabolism & Toxicology 12:6, pages 691-699.
Read now
Read now
Awadhesh Kumar Singh & Ritu Singh. (2015) Oral antidiabetic agents in gestational diabetes: a narrative review of current evidence. Expert Review of Endocrinology & Metabolism 10:2, pages 211-225.
Read now
Read now
Jamie Klein, Ron Charach & Eyal Sheiner. (2015) Treating diabetes during pregnancy. Expert Opinion on Pharmacotherapy 16:3, pages 357-368.
Read now
Read now
Articles from other publishers (36)
Michaela Rickert, Aaron B. Caughey & Amy M. Valent. (2023) Medications for Managing Preexisting and Gestational Diabetes in Pregnancy. Obstetrics and Gynecology Clinics of North America 50:1, pages 121-136.
Crossref
Crossref
Arianne Sweeting, Jencia Wong, Helen R Murphy & Glynis P Ross. (2022) A Clinical Update on Gestational Diabetes Mellitus. Endocrine Reviews 43:5, pages 763-793.
Crossref
Crossref
H. David McIntyre & Jeremy J. N. Oats. 2022. Endocrinology and Diabetes. Endocrinology and Diabetes
315
324
.
Dan-Qing Yu, Guan-Xin Xu, Xin-Yuan Teng, Jing-Wei Xu, Liang-Fang Tang, Chun Feng, Jin-Peng Rao, Min Jin & Li-Quan Wang. (2021) Glycemic control and neonatal outcomes in women with gestational diabetes mellitus treated using glyburide, metformin, or insulin: a pairwise and network meta-analysis. BMC Endocrine Disorders 21:1.
Crossref
Crossref
Victoria L. Rudland, Sarah A.L. Price, Ruth Hughes, Helen L. Barrett, Janet Lagstrom, Cynthia Porter, Fiona L. Britten, Sarah Glastras, Ian Fulcher, Peter Wein, David Simmons, H. David McIntyre & Leonie Callaway. (2020) ADIPS 2020 guideline for pre‐existing diabetes and pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology 60:6.
Crossref
Crossref
Ahmed Mohamed Maged. 2020. Gestational Diabetes Mellitus - An Overview with Some Recent Advances. Gestational Diabetes Mellitus - An Overview with Some Recent Advances.
Yoel Toledano, Eran Hadar & Moshe Hod. 2020. Obesity and Obstetrics. Obesity and Obstetrics
179
189
.
Khaled Fathy Helal, Mohammad Samir Badr, Mohamed El-Sayed Rafeek, Walid Mohamed Elnagar & Mohamed El-Bakry Lashin. (2020) Can glyburide be advocated over subcutaneous insulin for perinatal outcomes of women with gestational diabetes? A systematic review and meta-analysis. Archives of Gynecology and Obstetrics 301:1, pages 19-32.
Crossref
Crossref
Riki Bergel, Eran Hadar, Yoel Toledano & Moshe Hod. 2020. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
653
685
.
Rachel A. Blair, Emily A. Rosenberg & Nadine E. Palermo. (2019) The Use of Non-insulin Agents in Gestational Diabetes: Clinical Considerations in Tailoring Therapy. Current Diabetes Reports 19:12.
Crossref
Crossref
Margaret Eckert-Norton & Saundra Hendricks. 2019. Advanced Practice in Endocrinology Nursing. Advanced Practice in Endocrinology Nursing
817
835
.
Riki Bergel, Eran Hadar, Yoel Toledano & Moshe Hod. 2019. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
1
33
.
Matthew M. Finneran & Mark B. Landon. (2018) Oral Agents for the Treatment of Gestational Diabetes. Current Diabetes Reports 18:11.
Crossref
Crossref
Oded Langer. (2018) Pharmacological treatment of gestational diabetes mellitus: point/counterpoint. American Journal of Obstetrics and Gynecology 218:5, pages 490-499.
Crossref
Crossref
. (2018) ACOG Practice Bulletin No. 190: Gestational Diabetes Mellitus. Obstetrics & Gynecology 131:2, pages e49-e64.
Crossref
Crossref
Riki Bergel, Eran Hadar, Yoel Toledano & Moshe Hod. 2018. Diabetes Complications, Comorbidities and Related Disorders. Diabetes Complications, Comorbidities and Related Disorders
655
687
.
Riki Bergel, Eran Hadar, Yoel Toledano & Moshe Hod. 2018. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment. Diabetes. Epidemiology, Genetics, Pathogenesis, Diagnosis, Prevention, and Treatment
1
34
.
M. Shepherd, A. J. Brook, A. J. Chakera & A. T. Hattersley. (2017) Management of sulfonylurea-treated monogenic diabetes in pregnancy: implications of placental glibenclamide transfer. Diabetic Medicine 34:10, pages 1332-1339.
Crossref
Crossref
M.-V. Senat. (2017) Antidiabétiques oraux et grossesse. Médecine des Maladies Métaboliques 11:6, pages 510-517.
Crossref
Crossref
Rongjing Song, Ling Chen, Yue Chen, Xia Si, Yi Liu, Yue Liu, David M. Irwin & Wanyu Feng. (2017) Comparison of glyburide and insulin in the management of gestational diabetes: A meta-analysis. PLOS ONE 12:8, pages e0182488.
Crossref
Crossref
. (2017) Practice Bulletin No. 180: Gestational Diabetes Mellitus. Obstetrics & Gynecology 130:1, pages e17-e37.
Crossref
Crossref
Tim Cundy. 2017. Textbook of Diabetes. Textbook of Diabetes
909
938
.
Riki Bergel, Eran Hadar, Yoel Toledano & Moshe Hod. (2016) Pharmacological Management of Gestational Diabetes Mellitus. Current Diabetes Reports 16:11.
Crossref
Crossref
L M Harper, A V Glover, J R Biggio & A Tita. (2016) Predicting failure of glyburide therapy in gestational diabetes. Journal of Perinatology 36:5, pages 347-351.
Crossref
Crossref
Oded Langer. (2015) Oral hypoglycemic agents: do the ends justify the means?. Maternal Health, Neonatology and Perinatology 1:1.
Crossref
Crossref
Dana Carroll & Kristi W Kelley. (2015) In women with gestational diabetes requiring drug treatment, glibenclamide may be inferior to insulin and metformin: metformin (plus insulin when required) performs better than insulin. Evidence Based Medicine 20:4, pages 127-127.
Crossref
Crossref
Elizabeth Buschur, Florence Brown & Jennifer Wyckoff. (2015) Using Oral Agents to Manage Gestational Diabetes: What Have We Learned?. Current Diabetes Reports 15:2.
Crossref
Crossref
Jephthah O. Odiba & Mzwandile A. Mabhala. (2015) The Effectiveness of Glyburide Compared to Insulin in the Management of Gestational Diabetes Mellitus: A Systematic Review. Journal of Diabetes Mellitus 05:02, pages 58-66.
Crossref
Crossref
David Simmons. (2014) Safety Considerations with Pharmacological Treatment of Gestational Diabetes Mellitus. Drug Safety 38:1, pages 65-78.
Crossref
Crossref
R. I. G. Holt & K. D. Lambert. (2014) The use of oral hypoglycaemic agents in pregnancy. Diabetic Medicine 31:3, pages 282-291.
Crossref
Crossref
Ya-chang Zeng, Mu-jun Li, Yue Chen, Li Jiang, Su-mei Wang, Xiao-liang Mo & Bin-yi Li. (2014) The use of glyburide in the management of gestational diabetes mellitus: A meta-analysis. Advances in Medical Sciences 59:1, pages 95-101.
Crossref
Crossref
H. David McIntyre, Catherine Baskerville & Jeremy J. N. Oats. 2014. Endocrinology and Diabetes. Endocrinology and Diabetes
361
373
.
Yariv Yogev & Eyal SheinerGerard HA VisserHarold W de Valk. 2013. Obesity & Pregnancy. Obesity & Pregnancy
43
53
.
Anjali Tempe & Ronita Devi Mayanglambam. (2013) Glyburide as treatment option for gestational diabetes mellitus. Journal of Obstetrics and Gynaecology Research 39:6, pages 1147-1152.
Crossref
Crossref
Gerard H.A. Visser & Harold W. de Valk. (2013) Is the evidence strong enough to change the diagnostic criteria for gestational diabetes now?. American Journal of Obstetrics and Gynecology 208:4, pages 260-264.
Crossref
Crossref
Cigdem Tosun, Michael Koltz, David Kurland, Hina Ijaz, Melda Gurakar, Gary Schwartzbauer, Turhan Coksaygan, Svetlana Ivanova, Volodymyr Gerzanich & J. Simard. (2013) The Protective Effect of Glibenclamide in a Model of Hemorrhagic Encephalopathy of Prematurity. Brain Sciences 3:4, pages 215-238.
Crossref
Crossref